NUF2 and hepatocellular carcinoma: For example, Li et al. (20) examined a number of siRNA targets formulated in lipid nanoparticles and selected the best siRNA candidate targeting CDCA1 that resulted in a significant reduction in tumor growth in orthotopic models of HCC.